Clinical Research Directory
Browse clinical research sites, groups, and studies.
Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease
Sponsor: Bon-Kwon Koo
Summary
This study is a prospective, multicenter, open-label, observational study to investigate the impact of using drug-coated balloons (DCBs) in the treatment of coronary artery lesions in patients with multivessel coronary artery disease (MVD), as opposed to the default strategy of using only drug-eluting stents (DES). The investigators aim to assess changes in clinical practice towards a hybrid treatment strategy (DES and DCB) and its effects on clinical outcomes.
Key Details
Gender
All
Age Range
19 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2023-09-18
Completion Date
2026-10-31
Last Updated
2023-10-27
Healthy Volunteers
No
Interventions
drug-coated balloon
For the procedure, the drug-coated balloon (Agent®, Boston Scientific, USA) that can be used for both de-novo coronary lesions and in-stent restenosis lesions is used.
drug-eluting stent
When using drug-eluting stents, the latest 2nd generation drug-eluting stent (Synergy®, Boston Scientific, USA) should be used in accordance with the latest guidelines.
Locations (1)
Bon-Kwon Koo
Seoul, South Korea